Disparities in Phase II and III Clinical Trial Enrollment for Hematologic Malignancies

被引:0
|
作者
Gong, Inna Y. [1 ]
Rafinejad-Farahani, Bahar [2 ]
Majeed, Haris [2 ]
Soto, Mark [3 ]
Conti, Rena M. [4 ]
Unger, Joseph M. [5 ]
Guerra, Carmen E. [6 ]
Rosenthal, Meredith [3 ]
Rodin, Danielle [7 ]
机构
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Global Canc Program, Toronto, ON, Canada
[3] Harvard T H Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA
[4] Boston Univ, Questrom Sch Business, Dept Markets Publ Policy & Law, Boston, MA USA
[5] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[6] Univ Penn, Perelman Sch Med, Dept Med, Div Hematol & Oncol,Div Gen Med,Hosp Univ Penn, Philadelphia, PA USA
[7] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
关键词
D O I
10.1182/blood-2024-206450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5101 / 5101
页数:1
相关论文
共 50 条
  • [1] Strategies for Overcoming Disparities for Patients With Hematologic Malignancies and for Improving Enrollment on Clinical Trials
    Williams, Stephanie
    Ayers, Amy A.
    Hildebrandt, Michelle T.
    McNeill, Lorna H.
    Flowers, Christopher R.
    ONCOLOGY-NEW YORK, 2020, 34 (06): : 216 - 223
  • [2] Disparities in phase 1 cancer clinical trial enrollment
    Perni, Subha
    Moy, Beverly
    Nipp, Ryan D.
    CANCER, 2021, 127 (23) : 4464 - 4469
  • [3] Disparities by Ethnicity in Enrollment of a Clinical Trial
    Coon, Eric R.
    Schroeder, Alan R.
    Lion, K. Casey
    Ray, Kristin N.
    PEDIATRICS, 2022, 149 (02)
  • [4] Quality for all: Clinical trial enrollment and end-of-life care in solid and hematologic malignancies
    Rosen, Melissa R.
    Lambert, Katherine A.
    Nakatani, Morgan Megumi
    Ibrahim, Salam
    Troung, Tracy
    Feng, Kelvin
    Fournier, Chloe
    Kamal, Arif
    LeBlanc, Thomas William
    Havrilesky, Laura J.
    Davidson, Brittany Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Recruitment And Enrollment Of Asthmatics In A Phase II Clinical Trial
    Parikh, P. S.
    Ratanamaneechat, S.
    George, D.
    Comhair, S. A.
    Baran, J.
    Hughes, R.
    Koo, M.
    Mattox, E.
    Nagle, K.
    Naples, R.
    Peterson, L.
    Erzurum, S.
    Jain, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [6] Trends in Crossover of Patients in Phase III Clinical Trials for Hematologic Malignancies
    Yeh, Justin
    Pappoppula, Lakshmi Priyanka
    Kota, Vamsi
    Jillella, Anand
    Guddati, Achuta Kumar
    BLOOD, 2019, 134
  • [7] Just and Equitable Enrollment to Pivotal Clinical Trials in Hematologic Malignancies
    Chandhok, Namrata S.
    Sekeres, Mikkael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (32) : 3677 - +
  • [8] Disparities in perioperative clinical trial design and enrollment
    Lui, Briana
    White, Robert S.
    JOURNAL OF CLINICAL ANESTHESIA, 2020, 65
  • [9] Minority Enrollment in Phase II and III Clinical Trials in Urologic Oncology
    Owens-Walton, Jeunice
    Williams, Cheyenne
    Rompre-Brodeur, Alexis
    Pinto, Peter A.
    Ball, Mark W.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) : 1583 - +
  • [10] PHASE-II CLINICAL-TRIALS WITH VINDESINE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    MATHE, G
    HULHOVEN, R
    SOKAL, G
    BAYSSAS, M
    BELPOMME, D
    BOSLY, A
    CORNU, G
    DELANNOY, A
    DELUCA, L
    DEVASSAL, F
    FERRANT, A
    GOUVEIA, J
    HAYAT, M
    JASMIN, C
    MACHOVER, D
    MICHAUX, JL
    MISSET, JL
    MUSSET, M
    PICO, JL
    RIBAUD, P
    SCHWARTZENBERG, L
    ANTICANCER RESEARCH, 1981, 1 (01) : 1 - 9